血清及胆汁CEA、CA19-9、CA24-2在胆道良恶性梗阻性疾病中的诊断价值

刘涛; 罗耀兵; 张家耀

doi:10.3969/j.issn.1001-5256.2018.02.021

血清及胆汁CEA、CA19-9、CA24-2在胆道良恶性梗阻性疾病中的诊断价值

DOI: 10.3969/j.issn.1001-5256.2018.02.021

恩施土家族苗族自治州中心医院武汉大学恩施临床学院肝胆胰脾外科

详细信息

中图分类号: R575
计量
- 文章访问数: 2519
- HTML全文浏览量: 52
- PDF下载量: 415
- 被引次数: 0
出版历程
- 收稿日期: 2017-08-14
- 出版日期: 2018-02-20

Value of serum and biliary carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 24-2 in diagnosis of benign and malignant biliary obstructive diseases

Department of Hepatobiliary-pancreatic-splenic Surgery, The Central Hospital of Enshi Autonomous Prefecture, Enshi Clinical College of Wuhan University

摘要

摘要:
目的探讨血清及胆汁CEA、CA19-9、CA24-2检测对胆道良恶性梗阻性疾病的诊断价值。方法选择2015年6月-2016年12月来恩施土家族苗族自治州中心医院诊治的良性和恶性胆道梗阻患者各40例,收集入院时的血清和手术中的胆汁标本进行肿瘤标志物（CEA、CA19-9及CA24-2）检测。2组间比较采用t检验,并对各肿瘤标志物诊断胆道良恶性梗阻性疾病进行受试者工作特征曲线分析。结果胆道恶性梗阻性疾病组血清CA19-9、CA24-2水平均明显高于胆道良性梗阻性疾病组,差异均有统计学意义（t值分别为5.899、3.223,P值均<0.05）。胆道恶性梗阻性疾病组胆汁CEA、CA19-9及CA24-2水平均明显高于胆道良性梗阻性疾病组,差异均有统计学意义（t值分别为3.304、7.615、7.279,P值均<0.05）。胆道恶性梗阻性疾病组胆汁中肿瘤标志物CEA、CA19-9及CA24-2水平均明显高于血清,差异均有统计学意义（t值分别为3.297、4.975、3.993,P值均<0.05）;其中胆汁CA24-2的约登指数和受试者工作特征曲线下面积（AUC）最高,分别为0....
- 肿瘤标记,生物学 /
- 胆道疾病 /
- 血清 /
- 胆汁
Abstract:
Objective To investigate the value of serum and biliary carcinoembryonic antigen (CEA) , carbohydrate antigen 19-9 (CA19-9) , and carbohydrate antigen 24-2 (CA24-2) in the diagnosis of benign and malignant biliary obstructive diseases.Methods A total of 40 patients with benign biliary obstructive diseases and 40 with malignant ones, who were diagnosed and treated in The Central Hospital of Enshi Autonomous Prefecture from June 2015 to December 2016, were enrolled.Serum samples collected on admission and bile samples collected during surgery were used to measure the levels of tumor markers CEA, CA19-9, and CA24-2.The t-test was used for comparison between two groups, and a receiver operating characteristic (ROC) curve analysis was performed for each tumor marker in the diagnosis of benign and malignant biliary obstructive diseases.Results Compared with the benign group, the malignant group had significantly higher serum levels of CA19-9 and CA24-2 (t = 5.899 and 3.223, both P < 0.05) and biliary levels of CEA, CA19-9, and CA24-2 (t =3.304, 7.615, and 7.279, all P < 0.05) .In the patients with malignant biliary obstructive diseases, the levels of CEA, CA19-9, and CA24-2 in the bile were significantly higher than those in serum (t = 3.297, 4.975, and 3.993, all P < 0.05) .Biliary CA24-2 had the highest Youden index (0.75) and area under the ROC curve (AUC) (0.946) ; biliary CA19-9 had a Youden index of 0.74 and an AUC of 0.937, and serum CA19-9 had a Youden index of 0.68 and an AUC of 0.898.These three indices had a relatively high diagnostic value.Combined measurement of biliary CA24-2, serum CA19-9, and biliary CA19-9 had a sensitivity of 94.75%, a negative predictive value of 93.50%, and a Youden index of 0.82 in the diagnosis of malignant biliary obstructive diseases.Conclusion Biliary tumor markers have a great value in the diagnosis of malignant biliary obstructive diseases, and the combined measurement of biliary CA24-2, serum CA19-9, and biliary CA19-9 has the highest value in the differential diagnosis of benign and malignant biliary obstructive diseases.
- tumor markers, biological /
- bile duct diseases /
- serum /
- bile

HTML全文

参考文献(17)

[1]PATTANAPAIROJ S, SILSIRIVANIT A, MUISUK K, et al.Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach[J].Clin Biochem, 2015, 48 (10-11) :668-673.

[2]SLEGEL RL, MILLER KD, JEMAL A.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2015, 65 (1) :5-29.

[3]LI Y, LI DJ, CHEN J, et al.Application of joint detection of AFP, CA19-9, CA125 and CEA in identification and diagnosis of cholangiocarcinoma[J].Asian Pac J Cancer Prev, 2015, 16 (8) :3451-3455.

[4] SUI XL, TANG HH, XIAO GF, et al.Clinical efficacy and prognostic factors analysis of hilar cholangiocarnoma in 322 patients[J].Chin J Dig Surg, 2017, 16 (4) :391-397. (in Chinese) 隋鑫磊, 汤恢焕, 肖广发, 等.322例肝门部胆管癌的临床疗效及预后因素分析[J].中华消化外科杂志, 2017, 16 (4) :391-397.

[5]LUMACHI F, LORE G, TOZZOLI R, et al.Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma.A preliminary case-control study[J].Anticancer Res, 2014, 34 (11) :6663-6667.

[6]INCE AT, YILDIZ K, BAYSAL B, et al.Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions[J].Turk J Gastroenterol, 2014, 25 (2) :162-169.

[7]XU MF, SHAN JL, ZHONG ZY, et al.Systematic analysis of CA242 within serum multiple tumor markers chip and its clinical significance in cancer diagnosis[J].China J Modern Med, 2012, 22 (3) :41-46. (in Chinese) 许明芳, 单锦露, 仲召阳, 等.多肿瘤标志物蛋白芯片检测CA242在恶性肿瘤诊断中的价值[J].中国现代医学杂志, 2012, 22 (3) :41-46.

[8]NATSIOS A, VEZAKIS A, KAPAROS G, et al.Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease[J].J BUON, 2015, 20 (4) :1030-1036.

[9]HELLING TS.Caution in interpretation of the tumor marker CA 199in patients with obstructive jaundice:illustrative case reports[J].J Miss State Med Assoc, 2013, 54 (4) :96-99.

[10]SINGH S, TANG SJ, SREENARASIMHAIAH J, et al.The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma[J].Dig Dis Sci, 2011, 56 (8) :2491-2496.

[11]GU YL, LAN C, PEI H, et al.Applicative value of serum CA19-9, CEA, CA125 and CA242 in diagnosis and prognosis for patients with pancreatic cancer treated by concurrent chemoradiotherapy[J].Asian Pac J Cancer Prev, 2015, 16 (15) :6569-6573.

[12]HAN ZX, GONG J, ZHENG Y.Combined detection of serum carbohydrate antigens and CEA levels in patients with pancreatic cancer[J].Chin J Med Offic, 2016, 44 (10) :1052-1054. (in Chinese) 韩忠学, 巩静, 郑艳.血清糖类抗原与癌抗原对胰腺癌诊断价值[J].临床军医杂志, 2016, 44 (10) :1052-1054.

[13]CUI DP, ZHANG YC, GAO SQ, et al.Value of serum carbohydrate antigens 19-9 and 24-2 in diagnosis of benign and malignant biliary tract diseases[J].J Clin Hepatol, 2016, 32 (7) :1364-1367. (in Chinese) 崔大鹏, 张迎春, 高树全, 等.血清糖链抗原19-9、糖链抗原24-2对良恶性胆道疾病的诊断价值[J].临床肝胆病杂志, 2016, 32 (7) :1364-1367.

[14]LI JY, SONG JY, WANG JF, et al.Value of comb ined detection of AFP, CA19-9, and CEA in early diagnosis of primary liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1291-1295. (in Chinese) 李嘉妍, 宋金云, 王建芳, 等.AFP、CA19-9、CEA联合检测对原发性肝癌的早期诊断价值[J].临床肝胆病杂志, 2017, 33 (7) :1291-1295.

[15]ONAL C, COLAKOGLU T, ULUSAN SN, et al.Biliary obstruction induces extremely elevated serum CA 19-9 levels:case report[J].Onkologie, 2012, 35 (12) :780-782.

[16]WANG W, XU X, TIAN B, et al.The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer[J].Clin Chim Acta, 2017, 470 (7) :51-55.

[17]YAZGAN Y, ONCU K, KAPLAN M, et al.Malignant biliary obstruction significantly increases serum lipid levels:a novel biochemical tumor marker?[J].Hepatogastroenterology, 2012, 59 (119) :2079-2082.

施引文献

资源附件(0)

访问统计